Literature DB >> 20015982

A systemic neutrophil response precedes robust CD8(+) T-cell activation during natural respiratory syncytial virus infection in infants.

Michaël V Lukens1, Alma C van de Pol, Frank E J Coenjaerts, Nicolaas J G Jansen, Vera M Kamp, Jan L L Kimpen, John W A Rossen, Laurien H Ulfman, Carline E A Tacke, Marco C Viveen, Leo Koenderman, Tom F W Wolfs, Grada M van Bleek.   

Abstract

Severe primary respiratory syncytial virus (RSV) infections are characterized by bronchiolitis accompanied by wheezing. Controversy exists as to whether infants suffer from virus-induced lung pathology or from excessive immune responses. Furthermore, detailed knowledge about the development of primary T-cell responses to viral infections in infants is lacking. We studied the dynamics of innate neutrophil and adaptive T-cell responses in peripheral blood in relation to the viral load and parameters of disease in infants admitted to the intensive care unit with severe RSV infection. Analysis of primary T-cell responses showed substantial CD8(+) T-cell activation, which peaked during convalescence. A strong neutrophil response, characterized by mobilization of bone marrow-derived neutrophil precursors, preceded the peak in T-cell activation. The kinetics of this neutrophil response followed the peak of clinical symptoms and the viral load with a 2- to 3-day delay. From the sequence of events, we conclude that CD8(+) T-cell responses, initiated during primary RSV infections, are unlikely to contribute to disease when it is most severe. The mobilization of precursor neutrophils might reflect the strong neutrophil influx into the airways, which is a characteristic feature during RSV infections and might be an integral pathogenic process in the disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20015982      PMCID: PMC2820924          DOI: 10.1128/JVI.01807-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  Circulating CD10-/CD16low neutrophils provide a quantitative index of active bone marrow neutrophil release.

Authors:  Y Orr; J M Taylor; P G Bannon; C Geczy; L Kritharides
Journal:  Br J Haematol       Date:  2005-11       Impact factor: 6.998

2.  Peripheral blood cytokine responses and disease severity in respiratory syncytial virus bronchiolitis.

Authors:  L Bont; C J Heijnen; A Kavelaars; W M van Aalderen; F Brus; J T Draaisma; S M Geelen; H J van Vught; J L Kimpen
Journal:  Eur Respir J       Date:  1999-07       Impact factor: 16.671

3.  Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus.

Authors:  Darwyn Kobasa; Steven M Jones; Kyoko Shinya; John C Kash; John Copps; Hideki Ebihara; Yasuko Hatta; Jin Hyun Kim; Peter Halfmann; Masato Hatta; Friederike Feldmann; Judie B Alimonti; Lisa Fernando; Yan Li; Michael G Katze; Heinz Feldmann; Yoshihiro Kawaoka
Journal:  Nature       Date:  2007-01-18       Impact factor: 49.962

Review 4.  Immunity to respiratory viruses.

Authors:  Jacob E Kohlmeier; David L Woodland
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

5.  Diagnosing herpesvirus infections by real-time amplification and rapid culture.

Authors:  G J J van Doornum; J Guldemeester; A D M E Osterhaus; H G M Niesters
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

6.  Quantitative shedding patterns of respiratory syncytial virus in infants.

Authors:  C B Hall; R G Douglas; J M Geiman
Journal:  J Infect Dis       Date:  1975-08       Impact factor: 5.226

7.  Recombinant granulocyte colony-stimulating factor administration to healthy volunteers: induction of immunophenotypically and functionally altered neutrophils via an effect on myeloid progenitor cells.

Authors:  J M Kerst; M de Haas; C E van der Schoot; I C Slaper-Cortenbach; M Kleijer; A E von dem Borne; R H van Oers
Journal:  Blood       Date:  1993-12-01       Impact factor: 22.113

8.  Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice.

Authors:  B S Graham; L A Bunton; P F Wright; D T Karzon
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

9.  Expression patterns of the lipopolysaccharide receptor CD14, and the FCgamma receptors CD16 and CD64 on polymorphonuclear neutrophils: data from patients with severe bacterial infections and lipopolysaccharide-exposed cells.

Authors:  Christof Wagner; Reinhold Deppisch; Birgit Denefleh; Friederike Hug; Konrad Andrassy; G Maria Hänsch
Journal:  Shock       Date:  2003-01       Impact factor: 3.454

10.  Diagnostic value of real-time polymerase chain reaction to detect viruses in young children admitted to the paediatric intensive care unit with lower respiratory tract infection.

Authors:  Alma C van de Pol; Tom F W Wolfs; Nicolaas J G Jansen; Anton M van Loon; John W A Rossen
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

View more
  59 in total

1.  Pulmonary Dendritic Cell Subsets Shape the Respiratory Syncytial Virus-Specific CD8+ T Cell Immunodominance Hierarchy in Neonates.

Authors:  Allison M W Malloy; Tracy J Ruckwardt; Kaitlyn M Morabito; Annie W Lau-Kilby; Barney S Graham
Journal:  J Immunol       Date:  2016-11-28       Impact factor: 5.422

2.  Neutrophils regulate the lung inflammatory response via γδ T cell infiltration in an experimental mouse model of human metapneumovirus infection.

Authors:  Nagarjuna R Cheemarla; Ma Del Rocío Baños-Lara; Shan Naidu; Antonieta Guerrero-Plata
Journal:  J Leukoc Biol       Date:  2017-03-23       Impact factor: 4.962

Review 3.  Determinants of early life immune responses to RSV infection.

Authors:  Tracy J Ruckwardt; Kaitlyn M Morabito; Barney S Graham
Journal:  Curr Opin Virol       Date:  2016-03-15       Impact factor: 7.090

Review 4.  Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years.

Authors:  Peter L Collins; José A Melero
Journal:  Virus Res       Date:  2011-09-22       Impact factor: 3.303

5.  Responses against a subdominant CD8+ T cell epitope protect against immunopathology caused by a dominant epitope.

Authors:  Tracy J Ruckwardt; Cindy Luongo; Allison M W Malloy; Jie Liu; Man Chen; Peter L Collins; Barney S Graham
Journal:  J Immunol       Date:  2010-09-10       Impact factor: 5.422

Review 6.  The use of a neonatal mouse model to study respiratory syncytial virus infections.

Authors:  Stephania A Cormier; Dahui You; Srinivasa Honnegowda
Journal:  Expert Rev Anti Infect Ther       Date:  2010-12       Impact factor: 5.091

7.  Targeting CD137 enhances vaccine-elicited anti-respiratory syncytial virus CD8+ T cell responses in aged mice.

Authors:  Sujin Lee; Robert S Mittler; Martin L Moore
Journal:  J Immunol       Date:  2013-11-27       Impact factor: 5.422

8.  Viral shedding and immune responses to respiratory syncytial virus infection in older adults.

Authors:  Edward E Walsh; Derick R Peterson; Aja E Kalkanoglu; Frances Eun-Hyung Lee; Ann R Falsey
Journal:  J Infect Dis       Date:  2013-02-04       Impact factor: 5.226

9.  Effects of anti-g and anti-f antibodies on airway function after respiratory syncytial virus infection.

Authors:  Junyan Han; Katsuyuki Takeda; Meiqin Wang; Wanjiang Zeng; Yi Jia; Yoshiki Shiraishi; Masakazu Okamoto; Azzeddine Dakhama; Erwin W Gelfand
Journal:  Am J Respir Cell Mol Biol       Date:  2014-07       Impact factor: 6.914

10.  Development of an adenovirus-based respiratory syncytial virus vaccine: preclinical evaluation of efficacy, immunogenicity, and enhanced disease in a cotton rat model.

Authors:  Eun Kim; Kaori Okada; Judy A Beeler; Roberta L Crim; Pedro A Piedra; Brian E Gilbert; Andrea Gambotto
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.